Repurposing Old Drugs: Roflumilast as a Promising Therapeutic Option for Plaque Psoriasis
Introduction Psoriasis is a chronic, immune-mediated, inflammatory skin disease affecting approximately 2–3% of the global population.1,2 It is characterized by erythematous, scaly plaques that can cause significant physical discomfort, psychosocial burden …